vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Coterra (CTRA). Click either name above to swap in a different company.

Coterra is the larger business by last-quarter revenue ($1.8B vs $1.2B, roughly 1.4× Alignment Healthcare, Inc.). Coterra runs the higher net margin — 20.6% vs 0.9%, a 19.6% gap on every dollar of revenue. On growth, Coterra posted the faster year-over-year revenue change (23.8% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 11.8%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Coterra Energy Inc. is an American energy company engaged in hydrocarbon exploration based in Houston, Texas. The company has operations in the Permian Basin, Marcellus Shale, and the Anadarko Basin.

ALHC vs CTRA — Head-to-Head

Bigger by revenue
CTRA
CTRA
1.4× larger
CTRA
$1.8B
$1.2B
ALHC
Growing faster (revenue YoY)
CTRA
CTRA
+98.5% gap
CTRA
23.8%
-74.7%
ALHC
Higher net margin
CTRA
CTRA
19.6% more per $
CTRA
20.6%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
11.8%
CTRA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALHC
ALHC
CTRA
CTRA
Revenue
$1.2B
$1.8B
Net Profit
$11.4M
$368.0M
Gross Margin
Operating Margin
31.9%
Net Margin
0.9%
20.6%
Revenue YoY
-74.7%
23.8%
Net Profit YoY
23.9%
EPS (diluted)
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
CTRA
CTRA
Q1 26
$1.2B
Q4 25
$1.0B
$1.8B
Q3 25
$993.7M
$1.8B
Q2 25
$1.0B
$1.7B
Q1 25
$926.9M
$2.0B
Q4 24
$701.2M
$1.4B
Q3 24
$692.4M
$1.3B
Q2 24
$681.3M
$1.3B
Net Profit
ALHC
ALHC
CTRA
CTRA
Q1 26
$11.4M
Q4 25
$-11.0M
$368.0M
Q3 25
$3.7M
$322.0M
Q2 25
$15.7M
$511.0M
Q1 25
$-9.1M
$516.0M
Q4 24
$-31.1M
$297.0M
Q3 24
$-26.4M
$252.0M
Q2 24
$-24.0M
$220.0M
Operating Margin
ALHC
ALHC
CTRA
CTRA
Q1 26
Q4 25
-1.0%
31.9%
Q3 25
0.8%
26.8%
Q2 25
2.2%
40.9%
Q1 25
-0.6%
34.8%
Q4 24
-3.2%
22.5%
Q3 24
-2.8%
25.3%
Q2 24
-2.7%
23.0%
Net Margin
ALHC
ALHC
CTRA
CTRA
Q1 26
0.9%
Q4 25
-1.1%
20.6%
Q3 25
0.4%
18.3%
Q2 25
1.5%
29.5%
Q1 25
-1.0%
25.6%
Q4 24
-4.4%
20.5%
Q3 24
-3.8%
19.5%
Q2 24
-3.5%
17.1%
EPS (diluted)
ALHC
ALHC
CTRA
CTRA
Q1 26
Q4 25
$-0.04
$0.47
Q3 25
$0.02
$0.42
Q2 25
$0.07
$0.67
Q1 25
$-0.05
$0.68
Q4 24
$-0.15
$0.40
Q3 24
$-0.14
$0.34
Q2 24
$-0.13
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
CTRA
CTRA
Cash + ST InvestmentsLiquidity on hand
$705.6M
$114.0M
Total DebtLower is stronger
$3.8B
Stockholders' EquityBook value
$206.9M
$14.8B
Total Assets
$1.3B
$24.2B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
CTRA
CTRA
Q1 26
$705.6M
Q4 25
$604.2M
$114.0M
Q3 25
$644.1M
$98.0M
Q2 25
$503.8M
$192.0M
Q1 25
$479.5M
$186.0M
Q4 24
$470.6M
$2.0B
Q3 24
$381.0M
$843.0M
Q2 24
$363.7M
$1.3B
Total Debt
ALHC
ALHC
CTRA
CTRA
Q1 26
Q4 25
$323.2M
$3.8B
Q3 25
$322.7M
$3.9B
Q2 25
$322.3M
$4.2B
Q1 25
$321.9M
$4.3B
Q4 24
$321.4M
$3.5B
Q3 24
$212.0M
$2.1B
Q2 24
$211.7M
$2.6B
Stockholders' Equity
ALHC
ALHC
CTRA
CTRA
Q1 26
$206.9M
Q4 25
$179.3M
$14.8B
Q3 25
$161.9M
$14.7B
Q2 25
$141.0M
$14.6B
Q1 25
$108.1M
$14.2B
Q4 24
$99.9M
$13.1B
Q3 24
$114.5M
$13.0B
Q2 24
$123.7M
$13.0B
Total Assets
ALHC
ALHC
CTRA
CTRA
Q1 26
$1.3B
Q4 25
$1.1B
$24.2B
Q3 25
$1.1B
$24.0B
Q2 25
$1.0B
$24.0B
Q1 25
$895.6M
$24.0B
Q4 24
$782.1M
$21.6B
Q3 24
$692.3M
$20.1B
Q2 24
$716.3M
$20.8B
Debt / Equity
ALHC
ALHC
CTRA
CTRA
Q1 26
Q4 25
1.80×
0.26×
Q3 25
1.99×
0.27×
Q2 25
2.29×
0.29×
Q1 25
2.98×
0.30×
Q4 24
3.22×
0.27×
Q3 24
1.85×
0.16×
Q2 24
1.71×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
CTRA
CTRA
Operating Cash FlowLast quarter
$128.7M
$970.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
11.27×
2.64×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
CTRA
CTRA
Q1 26
$128.7M
Q4 25
$-50.4M
$970.0M
Q3 25
$144.6M
$971.0M
Q2 25
$29.1M
$936.0M
Q1 25
$16.6M
$1.1B
Q4 24
$-8.7M
$626.0M
Q3 24
$26.2M
$755.0M
Q2 24
$23.5M
$558.0M
Free Cash Flow
ALHC
ALHC
CTRA
CTRA
Q1 26
Q4 25
$-55.4M
Q3 25
$139.1M
Q2 25
$21.1M
Q1 25
$8.4M
Q4 24
$-18.0M
Q3 24
$16.9M
Q2 24
$11.8M
FCF Margin
ALHC
ALHC
CTRA
CTRA
Q1 26
Q4 25
-5.5%
Q3 25
14.0%
Q2 25
2.1%
Q1 25
0.9%
Q4 24
-2.6%
Q3 24
2.4%
Q2 24
1.7%
Capex Intensity
ALHC
ALHC
CTRA
CTRA
Q1 26
Q4 25
0.5%
Q3 25
0.6%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
1.3%
Q3 24
1.3%
Q2 24
1.7%
Cash Conversion
ALHC
ALHC
CTRA
CTRA
Q1 26
11.27×
Q4 25
2.64×
Q3 25
38.77×
3.02×
Q2 25
1.86×
1.83×
Q1 25
2.22×
Q4 24
2.11×
Q3 24
3.00×
Q2 24
2.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

CTRA
CTRA

Oil And Condensate$941.0M53%
Natural Gas Production$615.0M34%
Natural Gas Liquids Reserves$206.0M12%
Other Revenues$28.0M2%

Related Comparisons